The role of benzydamine in prevention and treatment of chemoradiotherapy-induced mucositis.

Ourania Nicolatou-GalitisPaolo BossiEster Orlandinull René-Jean Bensadoun

Published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2021)

Mucositis represents a major concern in H&N cancer patients and a clinical and economical issue. A multimodal and multidisciplinary approach is needed for its management. International guidelines recommend benzydamine for OM prevention and treatment in H&N cancer patients, but further "real world" trials should be designed.

Keyphrases

radiation induced
rectal cancer
oxidative stress
radiation therapy
pain management
combination therapy
locally advanced
drug induced
chemotherapy induced
replacement therapy